University of Missouri School of Medicine MU Health School of Medicine
News Divider
            


Stefan Sarafianos, PhD
Stefan Sarafianos, PhD, assistant professor of microbiology and immunology at the MU School of Medicine, has identified a new mutation that allows HIV to elude treatment. His research recently appeared in the Journal of Biological Chemistry and Nature Structural & Molecular Biology.


New Discoveries Make it Harder for HIV to Hide from Drugs


How the virus can escape even the best cocktail of treatments described in Nature journal

The virus that causes AIDS is chameleon-like in its replication. As HIV copies itself in humans, it constantly mutates into forms that can evade even the best cocktail of current therapies. Understanding exactly how HIV cells change as they reproduce is key to developing better tests and treatments for patients.

In the Journal of Biological Chemistry and Nature Structural & Molecular Biology, MU microbiologist and biochemist Stefan Sarafianos, PhD, reveals new findings that shed light on how HIV eludes treatment by mutating. His discoveries provide clues into HIV's mechanisms for resisting two main families of drugs.

"These findings are important because identifying a new mutation that affects HIV drug resistance allows physicians to make better decisions and prescribe the proper drugs," Sarafianos said. "Without that knowledge, therapy can be suboptimal and lead to early failure."

Patients with HIV are routinely tested to track the levels of the virus and immune cells in their body. Results of the tests help physicians gauge the health of their patients and prescribe the right mix of antiviral drugs. The drugs help prevent the spread of HIV in patients by inhibiting the virus' ability to replicate.

Sarafianos' lab determined the biochemical properties that allow strains of HIV with a specific mutation — the N348I mutation — to escape inhibition despite treatment with Nevirapine. The drug is commonly used in combination with other antiviral medications to decrease the amount of HIV in the blood. As a result of Sarafianos' discovery, at least one major company that manufactures HIV mutation-testing kits has modified its test to detect the N348I mutation.

Sarafianos' recent findings resulted from research supported by five National Institutes of Health grants. He recently received another $417,000 award from the NIH to assist him in developing modified antibodies for HIV therapy.

"Our latest efforts to design broadly neutralizing antibodies against HIV will hopefully expand our toolbox against the virus, which remains a constantly moving target," Sarafianos said.



Missouri Health News Network

Divider

News and Events

Fleming MU Department of Medicine Chair to Lead Medical Speciality Group
Fleming elected president of American College of Physicians

Howenstine MU Medical Students Shave Heads to Raise Funds for Cancer Research
Kickoff event begins efforts which raises thousands for pediatric cancer

Lefevre Lefevre Named Chair of U.S. Preventive Services Task Force
MU family and community medicine physician to lead national advisory group

Williamson MU Family Medicine Ranked Among Top 10 By U.S. News & World Report
Department ranked in top 10 for 21st consecutive year

Match Day Match Day Marks Start of New Chapter for 96 Medical Students
Announcement for residency placement sparks waves of emotion

Parker AAMC Awards Health System for Innovation in Clinical Care
LIGHT2 program recognized for combining technology, care coordination

Rantz MU Study Uses Video-Game Device With Goal of Preventing Patient Falls
Technology alerts health provider and offers valuable data about risk factors for falls

Krenz Compound improves cardiac function in mice with heart defect
MU study receives Outstanding Research Award in Pediatric Cardiology from AHA

Dr. Mohan Mohan Named Silver Fellow by Ophthalmology Organization
Researcher recognized for leadership and contributions to nanomedicine

Rural Track Pipeline MU Offers More Opportunity for Undergrads in Rural Medicine
Seven additional universities added to Bryant Scholars Pre-Admissions Program




Media Relations
University of Missouri Health System
One Hospital Drive, DC028.00
Columbia, MO 65212
24/7 on-call pager: (573) 876-0708

Mary Jenkins
jenkinsmg@health.missouri.edu
(573) 882-7299

Jeff Hoelscher
hoelscherj@health.missouri.edu
(573) 884-1608

Derek Thompson
thompsonder@health.missouri.edu
(573) 882-3323


Web Communications
University of Missouri Health System
One Hospital Drive, MA204G, DC018.00
Columbia, MO 65212
(573) 884-0298

Rich Gleba
glebar@health.missouri.edu
(573) 884-0298

Laura Gerding, APR
gerdingla@health.missouri.edu
(573) 882-9193

Velvet Hasner
hasnerv@health.missouri.edu
(573) 884-1115

Mike Muin
muinm@health.missouri.edu
(573) 884-7541



Printer Friendly
Follow us on Twitter!   Facebook   YouTube Videos  
Website created and maintained by the Office of Communications.
Contact the MU School of Medicine.
Revised: April 27, 2013 - Copyright © 2013 - The Curators of the University of Missouri System.
All rights reserved. DMCA and other copyright information. An equal opportunity/affirmative action institution.